The "Product & Company Valuation" course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world. This introductory course is very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors, which shape the risk profile of the company in question. This course optimally balances interactive lectures with practical group work exercises that are designed to help you practice the fundamental valuation tools & techniques taught throughout the day.Valuation is an inherently subjective task, which is made even more difficult in the life science industry due to its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies, IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the “Product Valuation and Deal Structuring” module where registrants will learn the commonly used rNPV (i.e., risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. Registrants will use an Excel-based tool designed specifically for this module, which can be taken home for future use.Topics covered in the Product & Company Valuation course include:Introduction to valuationAssessing a company prior to valuationCompany valuation and methodsProduct valuation and methodsDeal structuringThis one-day course will be held in person on June 15, 2025, in Boston. Registration opens on January 27, 2025. …

The “Applying Game Theory to Negotiations & Decision-Making” course is designed for executives and business development professionals interested in enhancing their skills in negotiations, influencing, decision-making, and game theory. This in-person course offers a unique experience for registrants to understand how to leverage the combination of these skills, allowing for a better understanding of how one’s counterpart in the negotiations might assess potential strategic options.Registrants will learn to anticipate as well as plan strategically ahead by making use of insights from game theory, with the aim to improve the outcome of your negotiations. The learnings from game theory will be applied to real-life pharma/biotech negotiation cases. This interactive course will help participants to sharpen their business development skills by increasing the speed and quality of their decision-making and enhance negotiation skills.Topics covered in the “Applying Game Theory to Negotiations & Decision-Making” course include:The science of strategic decision-making using game theoryThree phases of negotiationsFirst and second offer strategiesInteractive group negotiationsHow to behave with emotional negotiatorsMultiple equivalent simultaneous offersNOTE: This course has a capped number of participants; people are encouraged to register early to reserve a spot.This one-day course will be held in-person on Sunday, June 15, 2025, in Boston. Registration opens on January 27, 2025.Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.orgInstructors (click photos to view bios)